Covered recipient · General Payments record
SCOTT RYAN PEERENBOOM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,331.27
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.93 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $173.33 | 11 |
| Astellas Pharma US Inc | $68.23 | 2 |
| Novo Nordisk AS | $47.16 | 2 |
| GENZYME CORPORATION | $38.59 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $14.70 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139317660 | CMS |
| Astellas Pharma US Inc | $53.53 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139434992 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.62 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118046494 | CMS |
| GENZYME CORPORATION | $16.72 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139756478 | CMS |
| GENZYME CORPORATION | $21.87 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139756486 | CMS |
| Lilly USA, LLC | $2.56 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135345208 | CMS |
| Lilly USA, LLC | $4.59 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135369728 | CMS |
| Lilly USA, LLC | $19.53 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135400463 | CMS |
| Lilly USA, LLC | $11.15 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135345212 | CMS |
| Lilly USA, LLC | $20.37 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135411269 | CMS |
| Lilly USA, LLC | $2.90 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135345216 | CMS |
| Lilly USA, LLC | $19.96 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135418929 | CMS |
| Lilly USA, LLC | $22.66 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135421339 | CMS |
| Lilly USA, LLC | $18.41 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135345220 | CMS |
| Lilly USA, LLC | $21.72 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135382381 | CMS |
| Lilly USA, LLC | $29.48 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135382383 | CMS |
| Novo Nordisk Inc | $19.16 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097677150 | CMS |
| Novo Nordisk Inc | $28.00 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096879198 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.